Neurological Effects of Goal-directed Fluid Therapy in Beach Chair Position Shoulder Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03963063 |
Recruitment Status :
Completed
First Posted : May 24, 2019
Last Update Posted : January 21, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Postoperative Cognitive Dysfunction Anesthesia | Procedure: Goal-directed fluid therapy Procedure: Non goal-directed fluid therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 70 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Efficacy of Perioperative Goal-directed Fluid Therapy in Preventing Cerebral Desaturation and Postoperative Cognitive Dysfunction After Beach Chair Position Shoulder Surgery |
Actual Study Start Date : | June 27, 2019 |
Actual Primary Completion Date : | March 31, 2021 |
Actual Study Completion Date : | March 31, 2021 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Non Goal-directed Care Group |
Procedure: Non goal-directed fluid therapy
Patients in the group will receive standard perioperative care at the discretion of care-giving anesthesiologist, maintaining:
|
Experimental: Goal-directed Care Group |
Procedure: Goal-directed fluid therapy
Patients in the group will follow our mini-fluid challenge test goal-directed therapy protocol, maintaining:
|
- duration of cerebral desaturation events [ Time Frame: 3 hours ]patients will be monitored with bilateral cerebral oxymetry, and investigators will compare the duration of cerebral desaturation events
- incidence of cerebral desaturation events [ Time Frame: 3 hours ]patients will be monitored with bilateral cerebral oxymetry, and investigators will compare the incidence of cerebral desaturation events
- postoperative cognitive dysfunction assessed by the Taiwan version of questionnaire Qmci [ Time Frame: 3 days ]Qmci is a screening assessment developed to detect mild cognitive impairment. It's a 100-point test administered in approximately 10 minutes. A score of 60 or over is considered to be normal. The validity of the Taiwan version of Qmci has been established.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients receiving scheduled beach chair position shoulder surgery
Exclusion Criteria:
- pregnant women
- patients in intensive care units
- patients with respiratory failure [forced expiratory volume at one second (FEV1)/ forced vital capacity (FVC) < 70 % and FEV1 < 50%]
- patients with heart failure(NYHA score =III、IV)
- patients with chronic kidney disease (eGFR< 60 ml.min-1.1.73m-2)
- patients with liver failure
- patients with ongoing infection
- patients allergic to voluven

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03963063
Taiwan | |
Department of Anesthesiology, National Taiwan University Hospital | |
Taipei City, Taiwan, 100 |
Study Director: | Chun-Yu Wu, Ph.D. | National Taiwan University Hospital |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT03963063 |
Other Study ID Numbers: |
201903017RINB |
First Posted: | May 24, 2019 Key Record Dates |
Last Update Posted: | January 21, 2022 |
Last Verified: | October 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Postoperative Cognitive Complications Cognitive Dysfunction Cognition Disorders Neurocognitive Disorders |
Mental Disorders Postoperative Complications Pathologic Processes |